New Approach Methodologies (NAMs): By the numbers
We outline today’s animal-use landscape, the rise of NAMs, & how the Non-Animal Navigator supports…
Certara2025 年 12 月 10 日
New Approach Methodologies: Redefining Animal Testing Alternatives
Explore how New Approach Methodologies (NAMs) and advanced in silico and in vitro tools are…
Certara2025 年 12 月 10 日
A Guide to the FDA Announcement to Phase Out Animal Testing for Drugs
The FDA is phasing out animal testing of new drugs. Learn how Certara’s Non-Animal Navigator™…
Certara2025 年 11 月 17 日
Certara Study Shows Half of Americans Unaware of FDA/NIH Move to Phase Out Animal Testing of New Drugs
Certara’s new survey findings show that 50% of Americans are unaware of FDA and NIH…
Certara2025 年 11 月 12 日
Towards new approach methodologies for biological therapeutics: a novel model-informed metric to assess immunogenicity risk
Immunogenicity poses a significant challenge in biotherapeutics development due to the formation of anti-drug antibodies…
Danielle Pillsbury2025 年 11 月 7 日
In silico Safety and Toxicology assessment: ToxStudio®
Discover how Certara’s ToxStudio align with FDA’s roadmap to reduce animal testing and transform preclinical…
Certara2025 年 10 月 30 日
Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research
The article, "Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research," explores a…
Danielle Pillsbury2025 年 9 月 10 日
AI-driven drug discovery picks up as FDA pushes to reduce animal testing
AI is revolutionizing drug discovery and safety testing as drug developers adopt these technologies in…
Certara2025 年 9 月 9 日
How Pharma Can Transition to Non-animal Studies for Investigational Drugs
Pharma companies can ease the transition to non-animal studies for investigational drugs by leveraging NAMs…
Certara2025 年 7 月 25 日
